Letters sent to healthcare professionals in May 2016

In May 2016, letters were sent regarding Nexplanon (etonogestrel implant) and ERWINASE.

In May 2016, letters were sent regarding:

Article citation: Drug Safety Update vol 9 issue 11, June 2016: 4.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.